Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Beta Blocker Therapy in Moderate to Severe COPD (ANDA2)
This study is not yet open for participant recruitment.
Verified August 2012
by University of Dundee
Study NCT01656005 Information provided by University of Dundee
First Received on July 31, 2012. Last Updated on August 27, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Additional conditions recognized in this trial
Lung Diseases
Lung Diseases, Obstructive
Pulmonary Disease, Chronic Obstructive
Respiration Disorders
More general conditions related to this trial
Respiratory Tract Diseases
Interventions listed in this trial
Carvedilol
Bisoprolol
Beclometasone/formoterol
Tiotropium
Beclometasone
Additional drug interventions recognized in this trial
Adrenergic beta-Antagonists
Beclomethasone
Formoterol
More general drug interventions related to this trial
Adrenergic Agents
Adrenergic Agonists
Adrenergic alpha-1 Receptor Antagonists
Adrenergic alpha-Antagonists
Adrenergic Antagonists
Adrenergic beta-1 Receptor Antagonists
Adrenergic beta-2 Receptor Agonists
Adrenergic beta-Agonists
Anti-Asthmatic Agents
Anti-Inflammatory Agents
Antihypertensive Agents
Autonomic Agents
Bronchodilator Agents
Cardiovascular Agents
Cholinergic Agents
Cholinergic Antagonists
Glucocorticoids
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Parasympatholytics
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Respiratory System Agents
Sympatholytics
Therapeutic Uses
Vasodilator Agents
Sponsors listed in this trial
University of Dundee
Tenovus Scotland
Back to top of Main Content
